Bangalore, India, 560085
Dapagliflozin 10 mg + Gliclazide 60 mg (SR) is a combination oral antidiabetic medication formulated for adults with type 2 diabetes mellitus. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by reducing glucose reabsorption in the kidneys, promoting excretion of excess sugar through urine. Gliclazide (sustained release), a sulfonylurea, stimulates insulin release from pancreatic beta cells, helping to maintain stable blood sugar levels throughout the day. This dual-action therapy effectively improves glycemic control while minimizing post-meal glucose spikes. It is ideal for patients who require combination therapy when diet and exercise alone are insufficient.